Thromboprophylaxis for caesarean section - How can uptake and coverage be improved?

Journal of Obstetrics and Gynaecology

Volumn 24, Issue 4, 2004, Pages 392-394

  Gidiri, M ^a   Sant, M ^a   Philips, K ^a   Lindow, S W ^a  

^a DEPARTMENT OF OBSTETRICS AND GYNAECOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DALTEPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ARTICLE; CESAREAN SECTION; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG USE; EMBOLISM PREVENTION; FEMALE; HUMAN; INSTRUMENT; MAJOR CLINICAL STUDY; MEDICAL AUDIT; PATIENT COMPLIANCE; POSTOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; THROMBOEMBOLISM; THROMBOSIS PREVENTION;

ADULT; ANTICOAGULANTS; CESAREAN SECTION; CHEMOPREVENTION; ENGLAND; FEMALE; GUIDELINE ADHERENCE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MATERNAL HEALTH SERVICES; MEDICAL AUDIT; PRACTICE GUIDELINES; PREGNANCY; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOSIS;

EID: 3042533410     PISSN: 01443615     EISSN: None     Source Type: Journal    
DOI: 10.1080/01443610410001685510     Document Type: Article

References (10)

1. Bergqvist D., Lindgren B. and Matzsch T. (1996) Comparison of the cost of preventing post-operative deep vein thrombosis with either unfractionated or low molecular weight heparin. British Journal of Surgery, 83, 1548-1552.
2. British Medical Association (BMA) (2001) Parenteral anticoagulants. British National Formulary, 42, 114.
3. Burrows R.F., Gan E.T., Gallus A.S., Wallace E.M. and Burrows E.A. (2001) A randomised double-blind placebo controlled trial of low molecular weight heparin as prophylaxis in preventing venous thrombolic events after caesarean section: a pilot study. British Journal of Obstetrics and Gynaecology, 108, 835-839.
4. Lewis G. and Drife J. (2001) Why Mothers Die 1997-99. Confidential Enquiries into Maternal Deaths in the United Kingdom. London, RCOG Press.
5. Hull and East Yorkshire Hospitals NHS Trust (1999) Thromboprophylaxis and Acute Management of Venous and Pulmonary Thromboembolism. Guideline no. 38.
6. Madden S. and Porter T.F. (1999) Deep venous thrombosis: prophylaxis in gynaecology (controversies in gynaecology). Clinical Obstetrics and Gynaecology, 42, 895-901.
7. McLeod R.S., Geerts W.H., Sniderman K.W., Greenwood C., Gregoire R.C., Taylor B.M., Silverman R.E., Atkinson K.G., Bernstein M., Marshall J.C., Burul C.J., Anderson D.R., Ross T., Wilson S.R. and Barton P. (2001) Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the Canadian Colorectal DVT Prophylaxis Trial: a randomized, double-blind trial. Annals of Surgery, 233, 438-444.
8. Mismetti P., Laporte S., Darman J.Y., Buchmuller A. and Descousus H. (2001) Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. British Journal of Surgery, 88, 913-930.
9. Shaw R.W., Bonnar J. and Geer I. (1995) Report of the RCOG Working Party on Prophylaxis Against Thromboembolism in Gynaecology and Obstetrics. Consensus report and review. London, RCOG.
10. van Wijk F.H., Wolf H., Piek J.M.J. and Buller H.R. (2002) Administration of low molecular weight heparin within two hours before Caesarean section increases the risk of wound haematoma. British Journal of Obstetrics and Gynaecology, 109, 955-957.